New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014.

about

New developments in the pathology of malignant lymphoma: a review of the literature published from October 2014-December 2014.

Item

http://www.wikidata.org/entity/Q43184380

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

New developments in the pathol ...... om October 2014-December 2014.

@en

New developments in the pathol ...... om October 2014-December 2014.

@nl

type

Item

label

New developments in the pathol ...... om October 2014-December 2014.

@en

New developments in the pathol ...... om October 2014-December 2014.

@nl

prefLabel

New developments in the pathol ...... om October 2014-December 2014.

@en

New developments in the pathol ...... om October 2014-December 2014.

@nl

P1476

New developments in the pathol ...... om October 2014-December 2014.

@en

P2093

J Han van Krieken

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.

Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.

C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas

Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma

Seasonality of Burkitt's lymphoma in Uganda.

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.

Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

P2888

s12308-015-0240-9

P304

21-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12308-015-0240-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Han van Krieken

P577

2015-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25798206

http://www.w3.org/2001/XMLSchema#string

P932

4357643

http://www.w3.org/2001/XMLSchema#string